Follow us on:

Goodbody Health signing up pharmacies as fast as they can (VIDEO)

Giles
May 6, 2022
8:18 am

Goodbody Health Inc. (CSE: GBDY / AQSE: GBDY / FRA: 484 / OTC: SCNNF) CEO Marc Howells joins DirectorsTalk Interviews to update us on company progress after filing its financial statements for the year ending 2021.

Marc shares his views on a under resourced and over burdened NHS, a change in how people manage their health, how Goodbody Health is meeting the massive growing demand for its services and can the company continue to grow at such speed.

Goodbody Health is the parent company for its main brand name “Goodbody” and its trading subsidiaries “Goodbody Wellness Limited” and “Goodbody Botanicals Ltd”

Find more news, interviews, share price & company profile here for:Goodbody Health

Share this interview

Other Interviews

More News

Goodbody supports NHS health crusade with cholesterol tests February 15, 2022
Goodbody Health’s PhytoVista in a good place in terms of meeting current and future regulatory requirements (AQSE:GDBY) February 14, 2022
Goodbody Health to help prevent type 2 diabetes through blood glucose level checks February 10, 2022
Blood testing opens up market for early Cancer detection February 8, 2022
Goodbody Health putting quality and compliance first with extension of scope of ISO 17025 February 7, 2022
Goodbody Health to seize upon £690 million legal UK CBD market February 3, 2022
Goodbody Health aligned with NICE innovation agenda February 2, 2022
Goodbody Health perfectly aligned with NHS Long Term Plan January 31, 2022
Goodbody Health ISIN and SEDOL to be changed on 1st February 2022 January 31, 2022
Why getting your prostate checked is so important January 26, 2022

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.